Mydecine Innovations Group Inc. — Form D

Mydecine Innovations Group Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-15. The offering totals $1.4M, of which $628K was reported sold. Industry: Other.

Offering

Filed: 2022-06-15
Form: D
Accession: 0001062993-22-014841
Industry: Other
Exemptions: 06b
Total offering: $1.4M
Amount sold: $628K
Remaining: $765K
Investors: 1
Date of first sale: 2022-05-27
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-449213

Issuer

Name: Mydecine Innovations Group Inc.
CIK: 0001841626
Entity type: Corporation
Jurisdiction: BRITISH COLUMBIA, CANADA
Address: 810 - 789 W. PENDER STREET, VANCOUVER, A1, V6C 1H2
Phone: 604-687-2038

Officers, directors & promoters (13)

Name	Role	Location
Dr. Saeid Babaei	Director	Vancouver, A1
Joshua Bartch	Director	Vancouver, A1
Dr. Victoria Hale	Director	Vancouver, A1
Damon Michaels	Director	Dover, DE
Gordon Neal	Director	Vancouver, A1
Robert Roscow	Director	Vancouver, A1
Josephine Wu	Director	Vancouver, A1
Joshua Bartch	Executive Officer	Vancouver, A1
Dean Ditto	Executive Officer	Bainbridge Island, WA
Dr. Rakesh Jetly	Executive Officer	Vancouver, A1
Damon Michaels	Executive Officer	Dover, DE
Robert Roscow	Executive Officer	Vancouver, A1
Sanford Stein	Executive Officer	Vancouver, A1

More